NEU 3.48% $13.33 neuren pharmaceuticals limited

Ann: Trofinetide Rett syndrome clinical trial in girls aged 2-5, page-10

  1. 388 Posts.
    lightbulb Created with Sketch. 243
    I would read it that way. Why would you expand the study when so close to unblinding the P3 study unless you were observing some compelling improvements and wanted to be able to rapidly expand the target group.

    Imagine if they could give Trofinetide when they begin to deteriorate not afterwards, they may be able to avoid much of the disability.That would be a wonderful outcome!


 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
(20min delay)
Last
$13.33
Change
-0.480(3.48%)
Mkt cap ! $1.703B
Open High Low Value Volume
$13.82 $13.91 $13.32 $4.989M 369.3K

Buyers (Bids)

No. Vol. Price($)
1 500 $13.32
 

Sellers (Offers)

Price($) Vol. No.
$13.41 1680 2
View Market Depth
Last trade - 16.10pm 11/09/2024 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.